mr. greenwood. people are concerned about this. mr.mony the other day and the former ceo of valeant both side, basically, hey, i wish we hadn't done it the way we had and relied so much on raising prices. so what's the solution here? >> well, i wish they hadn't done it either. because that's not what our industry is about. our industry is about innovation, new products not taking old products that have been on the market forever and gouging the prices. when you say what about this and this meaning the spiraling cost of drugs, let me give you a statistic that most people don't acknowledge. in 2015 the net increase in pricing for drugs was 2.8%. 2.8%. so that's less than premiums, insurance premiums are increasing. that's less than people's out of pocket caused by insurance premiums systems is growing. so when we hear politicians and others talking about the skyrocketing drug prices, it's not really accurate. >> the narrative we often hear from the drug industry is the valeants and tur its are bad actors. when you see the 500% price incr